Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease

Rev Esp Enferm Dig. 2017 Jun;109(6):473-476. doi: 10.17235/reed.2017.4819/2016.

Abstract

The use of fecal microbiota transplantation in recurrent Clostridium difficile infection and coexistent inflammatory bowel disease remains unclear. A 61-year-old man with ulcerative pancolitis was diagnosed with a third recurrence of Clostridium difficile infection, previously treated with metronidazole, vancomycin and fidaxomicin. Fecal microbiota transplantation of an unrelated healthy donor was performed by the lower route. After a twelve month follow-up, the patient remains asymptomatic without Clostridium difficile infection relapses or inflammatory bowel disease flare-ups. Fecal microbiota transplantation is relatively simple to perform, well-tolerated, safe and effective in recurrent Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy failure.

Publication types

  • Case Reports

MeSH terms

  • Clostridioides difficile
  • Clostridium Infections / microbiology*
  • Clostridium Infections / therapy*
  • Colitis, Ulcerative / microbiology
  • Colitis, Ulcerative / therapy
  • Enterocolitis, Pseudomembranous / microbiology*
  • Enterocolitis, Pseudomembranous / therapy*
  • Fecal Microbiota Transplantation / methods*
  • Humans
  • Inflammatory Bowel Diseases / microbiology*
  • Inflammatory Bowel Diseases / therapy*
  • Male
  • Middle Aged
  • Recurrence